Phase II study of neo-adjuvant chemotherapy with paclitaxel and cisplatin given every 2 weeks for patients with a resectable squamous cell carcinoma of the esophagus

Annals of Oncology

Volumn 14, Issue 8, 2003, Pages 1253-1257

  Polee, M B ^a   Tilanus, H W ^a   Eskens, F A L M ^a   Hoekstra, R ^a   Van der Burg, M E L ^a   Siersema, P D ^a   Stoter, G ^a   Van der Gaast, A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Biweekly; Cisplatin; Esophageal cancer; Neo adjuvant; Paclitaxel

Indexed keywords

CISPLATIN; CLEMASTINE; DEXAMETHASONE; FLUOROURACIL; ONDANSETRON; PACLITAXEL; RANITIDINE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; ESOPHAGUS CARCINOMA; FATIGUE; FEASIBILITY STUDY; FEBRILE NEUTROPENIA; FEMALE; FREQUENCY ANALYSIS; GASTROINTESTINAL TOXICITY; GRANULOCYTOPENIA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MUCOSA INFLAMMATION; MYALGIA; NAUSEA AND VOMITING; NEUROTOXICITY; NEUTROPENIA; PATHOLOGY; PATIENT REFERRAL; PERFORMANCE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SENSORY NEUROPATHY; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT INDICATION; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PACLITAXEL; PROBABILITY; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0042510476     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdg328     Document Type: Article

References (14)

1. Millikan KW, Silverstein J, Hart V et al. A 15-year review of esophagectomy for carcinoma of the esophagus and cardia. Arch Surg 1995; 130: 617-624.
2. Muller JM, Erasmi H, Stelzner M et al. Surgical therapy of esophageal carcinoma. Br J Surg 1990; 77: 845-857.
3. Law S, Fok M, Chow S et al. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomised trial. J Thorac Cardiovasc Surg 1997; 114: 210-217.
4. Ilson DH, Ajani J, Bhalla K et al. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus. J Clin Oncol 1998; 16: 1826-1834.
5. Ilson DH, Forastiere A, Arquette M et al. A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus. Cancer J 2000; 6: 316-323.
6. Van der Gaast A, Kok TC, Kerkhofs L et al. Phase I study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced esophageal cancer. Br J Cancer 1999; 80: 1052-1057.
7. Polee MB, Eskens FALM, van der Burg MEL et al. Phase II study of a biweekly schedule of cisplatin and paclitaxel in patients with advanced esophageal cancer. Br J Cancer 2002; 86: 669-673.
8. World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment. WHO Offset Publication No.4. Geneva, Switzerland: World Health Organization 1979.
9. Kelsen DP, Ilson DH. Chemotherapy and combined-modality therapy for esophageal cancer. Chest 1995; 107: 224S-232S.
10. Hilgenberg AD, Carey RW, Wilkins EW Jr et al. Preoperative chemotherapy, surgical resection and selective postoperative therapy for squamous cell carcinoma of the esophagus. Ann Thorac Surg 1988; 45: 357-363.
11. Medical Research Council Esophageal Cancer Working Party. Surgical resection with or without preoperative chemotherapy in esophageal cancer: a randomised trial. Lancet 2002; 359: 1727-1733.
12. Kelsen DP, Ginsberg R, Pajak TF et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998; 339: 1979-1984.
13. Hulscher JBF, van Sandick JW, de Boer AG et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002; 347, 1662-1669.
14. Norton L. Kinetic concepts in the systemic drug therapy of breast cancer. Semin Oncol 1999; 26 (Suppl 2): 11-20.